- Home
- / LumiraDx
LumiraDx
Stock Price
$0
2024-08-19
Market Capitalization
$249.6 M
2024-03-08
Revenue
$254.5 M
FY, 2022
LumiraDx Summary
Company Summary
- Overview
- LumiraDx is a healthcare company providing diagnostics care services. It develops a cloud-based technology that supports healthcare professionals with data reporting, analysis, and decision-making. The company offers laboratory tests to diagnose bleeding disorders, infectious diseases, cardiovascular diseases, diabetes, etc.
- Type
- Public
- Status
- Active
- Founded
- 2014
- HQ
- London, GB | view all locations
- Website
- https://www.lumiradx.com/
- Cybersecurity rating
Table of Contents
Key People
David Scott, Chief Technology Officer and Director
David Walton, Chief Commercial Officer
Dorian Leblanc, Chief Financial Officer
Operating MetricsView all
Countries
98
263.0%
FY, 2021
Instruments
21K
162.5%
FY, 2021
Manufacturing Capacity per Month, MM
28
75.0%
FY, 2021
LocationsView all
23 locations detected
London, England HQ
United Kingdom
3 More London Riverside, 3 More London Riverside
Solana Beach, CA
United States
444 S Cedros Ave #101
Waltham, MA
United States
221 Crescent St #5th
Graz, Steiermark
Austria
Hasnerpl. 10
Sao Paulo, SP
Brazil
Av. Chucri Zaidan, 1550 - Vila Cordeiro
Cali, Valle del Cauca
Colombia
Av. 6 Bis Norte 27-51
LumiraDx Financials
Summary Financials
- Revenue (Q2, 2023)
- $21.0M
- Gross profit (Q2, 2023)
- ($9.9M)
- Net income (Q2, 2023)
- ($49.7M)
- Cash (Q2, 2023)
- $25.3M
- EBIT (Q2, 2023)
- ($48.4M)
- Enterprise value
- $347.0M